PITTSBURGH (KDKA) -- For type 2 diabetes, how about a shot that's just once a week? The FDA is considering a medicine that would be a weekly shot. And it's not insulin. It's a hormone called albiglutide -- to be marketed by Glaxo Smith Kline as Eperzan. "It lowers blood glucose...
NORTH CHICAGO, Ill., May 18, 2023– AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of adults with moderately to severely active Crohn’s disease who have had an inadequate response or intoleranc...
Patel and Miller Dovepress has become an attractive and highly prescribed therapy for treatment-naïve patients due to strong efficacy data, good tolerability, and its low pill burden.6,7,10,11 The development of additional single-tablet regimens continues to be sought as a result of concerns ...
The team also observed increases in the activity of genes related to diabetes (糖尿病) and risk of cancer. One of the biggest issues is that myths regarding sleep are constantly perpetuated. For example, have you ever heard that you can train yourself to need less or no sleep It’s ...
The standard twice-daily RBV regimen is interchangeable with the once-daily regimen. The once-daily regimen will improve compliance and opens the opportunity to combine RBV with other drugs dosed once a day, in a single pill. 展开 关键词: hepatitis C dose regimen ribavirin pegylated interferon ...
Given these data, on July 12 the FDA approved the first 1-pill-a-day antiretroviral formulation, Atripla. Atripla contains 2 agents made by Gilead Sciences, the NRTI emtricitabine (200 mg) and the nucleotide reverse transcriptase inhibitor tenofovir (300 mg), together with Bristol-Myers Squibb'...
In addition to the potential for a lower tacrolimus dose with LCPT, LCPT tablets have an advantageous once-a-day dosing. Multiple daily dosing can contribute to lack of adherence (7, 8, 9,16), and posttransplant drug regimens are often associated with high pill burden. Importantly, lack of...
Current research suggests that coffee consumption “doesn’t raise the risk of cardiovascular disease, and it seems to lower the risk ofsome chronic diseases, such astype 2 diabetes,” Qi said in a press release. “Given the effects that caffeine has on our bodies, we wanted to see if the...
Individuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, according to a presentation at the annual meeting of the European Association for the Study of Diabetes (EASD), held in Madrid, Spain (9–13 September). Amycretin, which i...
The study tested the Polycap, an experimental combo formulated by Cadila Pharmaceuticals of Ahmedabad, India. It contains low doses of threeblood pressuremedicines (atenolol, ramipril and the "water pill" thiazide), plus the generic version of the cholesterol-lowering statin drug Zocor, and a baby...